GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 48 filers reported holding GALERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497 | -97.5% | 2,834 | -55.3% | 0.00% | – |
| Q2 2023 | $19,799 | -86.5% | 6,346 | -88.9% | 0.00% | – |
| Q1 2023 | $146,266 | +25031.6% | 57,135 | +14512.5% | 0.00% | – |
| Q4 2022 | $582 | -70.9% | 391 | -63.9% | 0.00% | – |
| Q3 2022 | $2,000 | -66.7% | 1,082 | -73.7% | 0.00% | – |
| Q2 2022 | $6,000 | -53.8% | 4,107 | -26.0% | 0.00% | – |
| Q1 2022 | $13,000 | -98.5% | 5,548 | -97.1% | 0.00% | – |
| Q4 2021 | $874,000 | +1842.2% | 190,516 | +3297.2% | 0.00% | – |
| Q3 2021 | $45,000 | -21.1% | 5,608 | -5.0% | 0.00% | – |
| Q2 2021 | $57,000 | -47.2% | 5,901 | -52.1% | 0.00% | – |
| Q1 2021 | $108,000 | -34.1% | 12,307 | -23.0% | 0.00% | – |
| Q4 2020 | $164,000 | +556.0% | 15,987 | +475.7% | 0.00% | – |
| Q3 2020 | $25,000 | -39.0% | 2,777 | -52.1% | 0.00% | – |
| Q2 2020 | $41,000 | -8.9% | 5,793 | +22.0% | 0.00% | – |
| Q1 2020 | $45,000 | +45.2% | 4,747 | +101.5% | 0.00% | – |
| Q4 2019 | $31,000 | – | 2,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,083,712 | $40,582,000 | 2.92% |
| Novo Holdings A/S | 3,409,021 | $44,863,000 | 2.89% |
| NEA Management Company, LLC | 4,362,986 | $57,417,000 | 2.72% |
| SPHERA FUNDS MANAGEMENT LTD. | 471,439 | $6,204,000 | 0.51% |
| RA Capital Management | 1,054,178 | $13,873,000 | 0.42% |
| Rock Springs Capital Management LP | 500,000 | $6,580,000 | 0.21% |
| Tekla Capital Management LLC | 416,666 | $5,483,000 | 0.21% |
| Blackstone Inc. | 1,678,984 | $22,095,000 | 0.14% |
| Perceptive Advisors | 325,000 | $4,277,000 | 0.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,300,000 | $17,108,000 | 0.04% |